Unicon Pharma, a provider of compliance, validation and workforce solutions for the life sciences industry, announced on Wednesday that it is entering into a strategic partnership with VRR Life Sciences, a Bangalore, India-based leader in Computer System Validation (CSV) and regulatory technology services.
The partnership will operate under the unified brand VRR Life Sciences, a Unicon Company, to deliver scalable, tech-enabled compliance solutions to pharmaceutical, biotech and medical device clients across the United States.
By combining Unicon's US market presence with VRR's CSV expertise and offshore delivery model, the companies aim to provide enhanced value through speed, cost-efficiency and quality assurance.
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Boston Scientific to acquire Valencia Technologies to expand overactive bladder portfolio
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics